The Standalone and Consolidated Audited Financial results of the Company for the quarter and financial year ended 31st March, 2025 along with the Audit report issued by Statutory Auditors ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Riddhi Siddhi Gluco Biols' board on May 29, 2025 approved audited standalone and consolidated results for Q4 and FY ended March 31, 2025, with an unmodified (clean) opinion from auditors Batliboi & Purohit. Standalone revenue from operations fell sharply to Rs. 91.38 crore from Rs. 220.94 crore last year, while standalone profit after tax rose marginally to Rs. 94.12 crore vs Rs. 92.23 crore, helped by Rs. 120.56 crore of other income (largely interest and dividends from investments). The board recommended a final dividend of Rs. 3 per share (30% on equity). It also cleared two large related party transactions with Bluecraft Agro Private Limited: purchases/sales of goods up to Rs. 500 crore per year for 5 years, and investments, guarantees or securities in BAPL up to Rs. 350 crore. Cash flow from operations was negative at Rs. -37.48 crore vs Rs. -4.29 crore last year. The auditor flagged an emphasis of matter on a Rs. 308 lakh income tax contingent liability and on the Paper Division (subsidiary Shree Rama Newsprint) being classified as a discontinued operation with an additional Rs. 69.56 crore impairment recognized in Q3 FY25.
Clean audit opinion and steady dividend are positives, but the steep drop in operating revenue, negative operating cash flow, large related party deals with Bluecraft Agro (subject to shareholder approval), and a Rs. 69.56 crore paper division impairment raise concerns about core business health and governance. Shareholders should watch the July 28-31, 2025 SEBI/MPS hearings and the outcome of Bluecraft Agro transactions.